← FDA Drug Approvals (Drugs@FDA)

THIOTEPA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2018-05-04

Drug application

FDA Application #

ANDA209150

Application type

Abbreviated New Drug Application (Generic)

Brand name

THIOTEPA

Generic name

THIOTEPA

Active ingredients

THIOTEPA

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HENGRUI PHARMA

Manufacturer

Sagent Pharmaceuticals

First approval

2018-05-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown